Seeking Alpha

Barclays takes a dimmer view of shares of Pfizer (PFE), downgrading the drugmaker to Equal...

Barclays takes a dimmer view of shares of Pfizer (PFE), downgrading the drugmaker to Equal Weight and cutting its price target by $2 to $19. Analysts see limited upside potential in the near-term, and say patent expiration will kick in and pressure the firm in the long-term. Shares -0.5% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|